Epitalon Peptide: Telomerase Activation and Longevity Research
Epitalon (Epithalon) is a synthetic tetrapeptide derived from the pineal gland. This overview covers its mechanisms of action, research findings on telomerase activation, and relevance to longevity science.
Dr. Marcus Chen
Senior Research Scientist
Epitalon (also spelled Epithalon; sequence Ala-Glu-Asp-Gly) is a synthetic analogue of Epithalamin, a natural polypeptide extracted from the pineal gland of cattle. Developed by the St. Petersburg Institute of Bioregulation and Gerontology in the late 1980s, it has become one of the most-studied peptides in the context of biological aging and telomere biology.
Mechanism of Action
Epitalon's primary documented mechanism is stimulation of telomerase — the enzyme that extends telomere sequences (TTAGGG repeats) at chromosome ends. Telomere shortening with each cell division is a hallmark of cellular senescence; telomerase counteracts this process.
- Telomerase induction: In vitro studies show increased TERT (telomerase reverse transcriptase) expression in human somatic cells treated with Epitalon.
- Melatonin regulation: Epitalon restores age-related decline in pineal melatonin secretion in animal models, potentially contributing to circadian and immune benefits.
- Antioxidant activity: Reduction of reactive oxygen species (ROS) has been observed in treated cell lines, possibly via upregulation of endogenous antioxidant enzymes.
Key Research Findings
Russian gerontology teams led by Vladimir Khavinson have published extensively on Epitalon across cell culture, rodent, and limited human cohort studies:
- A 2001 Neuroendocrinology Letters study reported telomere elongation and increased telomerase activity in human fetal fibroblasts after Epitalon treatment.
- Long-term rodent studies (up to 25 years of published follow-up) reported extended median lifespan and reduced tumour incidence in treated cohorts versus controls.
- A 2006 study showed normalisation of nocturnal melatonin profiles in elderly subjects following Epithalamin administration — effects not yet fully replicated for the synthetic tetrapeptide alone.
Peptide Characteristics
| Property | Value |
|---|---|
| Sequence | Ala-Glu-Asp-Gly (AEDG) |
| Molecular weight | 390.35 g/mol |
| Form | Lyophilised powder |
| Typical research dose | 5–10 mg per course |
| Route (research) | Subcutaneous or IV injection |
Research Context
Most published Epitalon studies originate from a single Russian research group, which limits independent replication. Western peer-reviewed validation remains sparse. Researchers evaluating this peptide should treat existing data as hypothesis-generating rather than conclusive. Nonetheless, Epitalon continues to generate interest among longevity researchers owing to its telomerase-activating profile and apparent low toxicity in animal models.
For researchers stocking Epitalon alongside other longevity-oriented peptides, cross-referencing with the full Myotrope catalogue may help identify complementary compounds for panel-based studies.
References
- Khavinson VKh, et al. (2001). Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Neuroendocrinology Letters, 22(6), 417–423.
- Anisimov VN, Khavinson VKh. (2010). Peptide bioregulation of aging: results and prospects. Biogerontology, 11(2), 139–149.
- Korkushko OV, et al. (2006). Normalizing effect of Epithalamin on daily melatonin profile. Neuroendocrinology Letters, 27(1–2), 170–174.
